Picture of Corline Biomedical AB logo

CLBIO — Corline Biomedical AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Corline Biomedical: pre-clinical study regarding Renaparin shows very high tolerability

Nov 10 (Reuters) - Corline Biomedical AB  CLBIO.ST : 
    * Pre-clinical study regarding Renaparin shows very high tolerability 
 
Source text for Eikon:  ID:nHUG91MHKy  
     
Further company coverage:  CLBIO.ST  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))

Recent news on Corline Biomedical AB

See all news